OptiBiotix Health Share News (OPTI)

OptiBiotix Health Information

Buy OPTI Shares
Add OPTI to Watchlist
Add OPTI to Alert

Share Price Information for OptiBiotix Health (OPTI)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 18.00

Bid: 17.50

Ask: 18.50

Change: 0.00 (0.00%)

Spread: 1.00 (5.714%)

Open: 18.00

High: 18.00

Low: 18.00

Prev. Close: 18.00

Last checked at -

OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Tue, 21st Feb 2023 14:15

(Alliance News) - OptiBiotix Health PLC on Tuesday said that Rene Kamminga, Chief Executive Officer of subsidiary OptiBiotix Ltd, will leave the business next week Tuesday.

The York, England-based probiotics developer tackling obesity, cardiovascular diseases and lifestyle conditions announced it appointed its CEO Stephen O'Hara as CEO of the subsidiary.

O'Hara "will lead a minor restructuring of the business," OptiBiotix added.

Optibiotix shares were 2.8% lower at 12.89 pence each in London on Tuesday afternoon.

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

10 Aug 2021 11:24

OptiBiotix extends deal with Seed Health to other territories

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has extended the territories of its original agreement with Seed Health, for the production, promotion, marketing and commercialisation of products containing 'LPLDL'.

5 Aug 2021 18:07

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

5 Aug 2021 13:43

OptiBiotix revenues see healthy rise in first half

(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.

5 Aug 2021 10:44

Latest Share Chat

OptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

OptiBiotix extends deal with Seed Health to other territories

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

OptiBiotix revenues see healthy rise in first half

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

OptiBiotix operating losses narrow as revenue surges

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

Optibiotix names René Kamminga as CEO of subsidiary

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

Latest Share Chat

OptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Login to your account

Quickpicks are a member only feature

Login to your account